Bryn Mawr Trust Names John Kveragas as Senior Vice President, Chief Audit Officer
August 20, 2020 15:00 ET
|
Bryn Mawr Bank Corporation
BRYN MAWR, Pa., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Bryn Mawr Trust (BMT), wholly owned by Bryn Mawr Bank Corporation (NASDAQ: BMTC– the “Corporation”), today announces that John E. Kveragas, Jr.,...
RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
August 11, 2020 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RAPS Euro Convergence to be Held Online and In-Person in Brussels, 26–30 October
July 09, 2020 12:36 ET
|
Regulatory Affairs Professionals Society (RAPS)
Rockville, MD, USA, July 09, 2020 (GLOBE NEWSWIRE) -- The Regulatory Affairs Professionals Society (RAPS) announced today that the format for its Euro Convergence 2020, taking place 26–30 October in...
SweeGen’s Sugar Reduction Solutions Expand with Singapore Approval for Next Generation Bestevia Stevia Sweeteners Rebs D and E
June 09, 2020 13:08 ET
|
SweeGen, Inc.
Rancho Santa Margarita, Calif., June 09, 2020 (GLOBE NEWSWIRE) -- Asia-Pacific brands now have access to an expanded portfolio of sugar reduction solutions with the approval of SweeGen’s Bestevia Rebs...
RenovaCare Strengthens FDA Program with Leading U.S. Regulatory Group and Significant Investment
May 28, 2020 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., May 28, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia
May 22, 2020 16:15 ET
|
Zealand Pharma
Company Announcement – No. 28 / 2020 Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia The dasiglucagon...
Former Mississippi Department of Environmental Quality Executive Director Rejoins Butler Snow
February 27, 2020 11:35 ET
|
Butler Snow
RIDGELAND, Miss., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Gary C. Rikard has rejoined Butler Snow after a five-year stint as executive director of the Mississippi Department of Environmental Quality...
RAPS 2020 Board of Directors Begins Term, Welcomes Kimberly Trautman, Frank Pokrop and Sabina Hoekstra-van den Bosch
January 21, 2020 11:28 ET
|
Regulatory Affairs Professionals Society (RAPS)
Rockville, MD, USA, Jan. 21, 2020 (GLOBE NEWSWIRE) -- The board of directors of the Regulatory Affairs Professionals Society (RAPS) officially began its 2020 term on 1 January. Don Boyer, a former...
Paul Sidney加入Altasciences，担任合规与监管事务高级总监
January 10, 2020 10:00 ET
|
Altasciences Company Inc.
魁北克省拉瓦尔, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Altasciences宣布Paul Sidney加入其合规与法规事务团队，担任高级总监。Paul在Charles River Laboratories工作的丰富经验，加上他直接参与各种关键监管计划的经验，使他在药物开发领域的的制药公司、CRO和监管代表中受到高度赞誉。 ...
Paul Sidney Joins Altasciences as Senior Director, Compliance and Regulatory Affairs
January 09, 2020 09:13 ET
|
Altasciences Company Inc.
LAVAL, Quebec, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Altasciences announced the addition of Paul Sidney to their Compliance and Regulatory Affairs team as Senior Director. Paul’s extensive experience...